Literature DB >> 23625220

Pneumolysin-mediated expression of β-defensin 2 is coordinated by p38 MAP kinase-MKP1 in human airway cells.

Yong-Jae Kim1, Hee-Sung Shin, Jung-Hoon Lee, Yong Woo Jung, Hyong-Bai Kim, Un-Hwan Ha.   

Abstract

Antimicrobial peptides act as important innate immune defense mediators against invading microbes such as Streptococcus pneumoniae. Among a number of antimicrobial peptides, β-defensin 2 (BD2) has strong antimicrobial activity against S. pneumoniae. However, little is known about the molecular signaling mechanisms leading to the BD2 expression. Here, we report that BD2 is strongly induced by S. pneumoniae in human airway cells including human middle-ear cells. Among diverse pneumococcal virulence factors, pneumolysin is required for inducing BD2 whose expression is under the control of p38 mitogen-activated protein kinase (MAPK). Pneumolysin also selectively regulates the expression of MAPK phosphatase 1 (MKP1), which inhibits the p38 signaling pathway, thereby leading to upregulation of BD2 to mount an effective defense against S. pneumoniae infection. These results provide novel insights into the molecular mechanisms underlying the coordinative regulation of BD2 expression via p38-MKP1 in the pathogenesis of airway infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625220     DOI: 10.1007/s12275-013-2579-x

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  34 in total

1.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

Review 2.  Human antimicrobial peptides: defensins, cathelicidins and histatins.

Authors:  Kris De Smet; Roland Contreras
Journal:  Biotechnol Lett       Date:  2005-09       Impact factor: 2.461

3.  Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium.

Authors:  Stefanie Scharf; Janine Zahlten; Kolja Szymanski; Stefan Hippenstiel; Norbert Suttorp; Philippe Dje N'Guessan
Journal:  Exp Lung Res       Date:  2012-03       Impact factor: 2.459

4.  Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.

Authors:  Q Li; G Estepa; S Memet; A Israel; I M Verma
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

5.  Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia.

Authors:  H Ishimoto; H Mukae; Y Date; T Shimbara; M S Mondal; J Ashitani; T Hiratsuka; S Kubo; S Kohno; M Nakazato
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

6.  A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae.

Authors:  Unhwan Ha; Jae Hyang Lim; Hirofumi Jono; Tomoaki Koga; Amit Srivastava; Richard Malley; Gilles Pagès; Jacques Pouysségur; Jian-Dong Li
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 7.  Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.

Authors:  Tobias Welte; Thomas Köhnlein
Journal:  Semin Respir Crit Care Med       Date:  2009-03-18       Impact factor: 3.119

8.  IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide.

Authors:  Fan Yang; Eric Tang; Kunliang Guan; Cun-Yu Wang
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

9.  Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III.

Authors:  O T Avery; C M MacLeod; M McCarty
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

10.  Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Authors:  Haa-Yung Lee; Ali Andalibi; Paul Webster; Sung-Kyun Moon; Karen Teufert; Sung-Ho Kang; Jian-Dong Li; Mitsuyoshi Nagura; Tomas Ganz; David J Lim
Journal:  BMC Infect Dis       Date:  2004-05-05       Impact factor: 3.090

View more
  4 in total

1.  Paeoniflorin upregulates β-defensin-2 expression in human bronchial epithelial cell through the p38 MAPK, ERK, and NF-κB signaling pathways.

Authors:  Yuying Gan; Xuefan Cui; Ting Ma; Yanliang Liu; Amin Li; Mao Huang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 2.  The Yin and Yang of Pneumolysin During Pneumococcal Infection.

Authors:  Joana M Pereira; Shuying Xu; John M Leong; Sandra Sousa
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 3.  Effector triggered immunity.

Authors:  Rajmohan Rajamuthiah; Eleftherios Mylonakis
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 4.  Streptococcus pneumoniae and Its Virulence Factors H2O2 and Pneumolysin Are Potent Mediators of the Acute Chest Syndrome in Sickle Cell Disease.

Authors:  Joyce Gonzales; Trinad Chakraborty; Maritza Romero; Mobarak Abu Mraheil; Abdullah Kutlar; Betty Pace; Rudolf Lucas
Journal:  Toxins (Basel)       Date:  2021-02-17       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.